Showing 1 - 6 of 6
DOI: 10.2165/0019053-200826100-00009
Persistent link: https://www.econbiz.de/10004997788
While the EuroQOL instrument (EQ-5D) is being considered and used in clinical trials in the United States and Canada, and in large international multicentre studies, population weights for the instrument have never been established in North America. The primary purpose of this investigation was...
Persistent link: https://www.econbiz.de/10005404803
With the advent of highly active antiretroviral therapy (HAART), HIV-infected patients are living longer and are concerned not only with a treatment's ability to extend their life but also with the quality of the life they are able to lead. Regulatory authorities are also paying closer attention...
Persistent link: https://www.econbiz.de/10005590447
Uncertainty in the decision-making process for reimbursement of health technologies could be reduced if additional information were available. Although methods to evaluate the monetary value of the uncertainty have been previously described, an economic evaluation of alternative methods to...
Persistent link: https://www.econbiz.de/10005590472
We study how reminding high-risk patients with chronic disease of their upcoming primary care appointments impacts their health care and behaviors. We leverage a natural experiment in Chile's public healthcare system that sent reminders before preventative care appointments to over 300,000...
Persistent link: https://www.econbiz.de/10014337875
Patients rely on medical care providers to act in their best interests because providers understand disease pathology and appropriate treatment much better than patients. Providers, however, not only give advice (diagnose) but also deliver (sell) treatments based on that advice. This creates a...
Persistent link: https://www.econbiz.de/10014486242